Insufficient scRNA-seq data for expression of IL4 at single-cell level.
Insufficient scRNA-seq data for expression of IL4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 84% | 3.32 | 549 / 653 | 10% | 0.21 | 60 / 605 |
spleen | 92% | 4.80 | 221 / 241 | 0% | 0 | 0 / 0 |
prostate | 90% | 5.36 | 221 / 245 | 1% | 0.01 | 4 / 502 |
lung | 83% | 4.35 | 478 / 578 | 3% | 0.06 | 39 / 1155 |
kidney | 83% | 3.38 | 74 / 89 | 3% | 0.04 | 25 / 901 |
ovary | 85% | 3.71 | 153 / 180 | 0% | 0.01 | 2 / 430 |
uterus | 84% | 3.85 | 143 / 170 | 1% | 0.01 | 3 / 459 |
adrenal gland | 78% | 2.24 | 201 / 258 | 4% | 0.06 | 9 / 230 |
blood vessel | 78% | 3.32 | 1037 / 1335 | 0% | 0 | 0 / 0 |
breast | 75% | 2.70 | 346 / 459 | 2% | 0.03 | 25 / 1118 |
skin | 74% | 2.34 | 1333 / 1809 | 1% | 0.02 | 6 / 472 |
adipose | 69% | 2.23 | 833 / 1204 | 0% | 0 | 0 / 0 |
bladder | 67% | 1.95 | 14 / 21 | 1% | 0.24 | 4 / 504 |
peripheral blood | 66% | 10.33 | 615 / 929 | 0% | 0 | 0 / 0 |
intestine | 60% | 1.60 | 584 / 966 | 0% | 0.01 | 2 / 527 |
pancreas | 55% | 1.29 | 181 / 328 | 4% | 0.20 | 8 / 178 |
esophagus | 59% | 1.43 | 853 / 1445 | 1% | 0.01 | 1 / 183 |
brain | 55% | 1.43 | 1462 / 2642 | 2% | 0.02 | 11 / 705 |
stomach | 53% | 1.19 | 190 / 359 | 3% | 0.07 | 10 / 286 |
heart | 47% | 1.01 | 401 / 861 | 0% | 0 | 0 / 0 |
liver | 34% | 0.58 | 76 / 226 | 2% | 0.03 | 7 / 406 |
lymph node | 0% | 0 | 0 / 0 | 31% | 1.36 | 9 / 29 |
muscle | 27% | 0.41 | 218 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0042092 | Biological process | type 2 immune response |
GO_0042976 | Biological process | activation of Janus kinase activity |
GO_0042116 | Biological process | macrophage activation |
GO_2000352 | Biological process | negative regulation of endothelial cell apoptotic process |
GO_0045348 | Biological process | positive regulation of MHC class II biosynthetic process |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_1903845 | Biological process | negative regulation of cellular response to transforming growth factor beta stimulus |
GO_0042325 | Biological process | regulation of phosphorylation |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0097028 | Biological process | dendritic cell differentiation |
GO_0045191 | Biological process | regulation of isotype switching |
GO_0050776 | Biological process | regulation of immune response |
GO_2000553 | Biological process | positive regulation of T-helper 2 cell cytokine production |
GO_0150079 | Biological process | negative regulation of neuroinflammatory response |
GO_0035771 | Biological process | interleukin-4-mediated signaling pathway |
GO_1901857 | Biological process | positive regulation of cellular respiration |
GO_0048260 | Biological process | positive regulation of receptor-mediated endocytosis |
GO_0006955 | Biological process | immune response |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0048304 | Biological process | positive regulation of isotype switching to IgG isotypes |
GO_1900223 | Biological process | positive regulation of amyloid-beta clearance |
GO_1903660 | Biological process | negative regulation of complement-dependent cytotoxicity |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_2001171 | Biological process | positive regulation of ATP biosynthetic process |
GO_0043011 | Biological process | myeloid dendritic cell differentiation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0010633 | Biological process | negative regulation of epithelial cell migration |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0150076 | Biological process | neuroinflammatory response |
GO_0048295 | Biological process | positive regulation of isotype switching to IgE isotypes |
GO_0042110 | Biological process | T cell activation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0030183 | Biological process | B cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0008083 | Molecular function | growth factor activity |
GO_0005136 | Molecular function | interleukin-4 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL4 |
Protein name | Interleukin-4 (IL-4) (B-cell stimulatory factor 1) (BSF-1) (Binetrakin) (Lymphocyte stimulatory factor 1) (Pitrakinra) Interleukin-4 (IL-4) (B-cell stimulatory factor 1) (Lymphocyte stimulatory factor 1) Interleukin-4 (B-cell stimulatory factor 1) (Lymphocyte stimulatory factor 1) |
Synonyms | hCG_24113 |
Description | FUNCTION: Cytokine secreted primarily by mast cells, T-cells, eosinophils, and basophils that plays a role in regulating antibody production, hematopoiesis and inflammation, and the development of effector T-cell responses . Induces the expression of class II MHC molecules on resting B-cells. Enhances both secretion and cell surface expression of IgE and IgG1 . Regulates also the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes and monocytes . Positively regulates IL31RA expression in macrophages. Stimulates autophagy in dendritic cells by interfering with mTORC1 signaling and through the induction of RUFY4. In addition, plays a critical role in higher functions of the normal brain, such as memory and learning (By similarity). Upon binding to IL4, IL4R receptor dimerizes either with the common IL2R gamma chain/IL2RG to produce the type 1 signaling complex, located mainly on hematopoietic cells, or with the IL13RA1 to produce the type 2 complex, which is expressed also on nonhematopoietic cells . Engagement of both types of receptors initiates JAK3 and to a lower extend JAK1 phosphorylation leading to activation of the signal transducer and activator of transcription 6/STAT6 . . FUNCTION: Participates in at least several B-cell activation processes as well as of other cell types. It is a costimulator of DNA-synthesis. It induces the expression of class II MHC molecules on resting B-cells. It enhances both secretion and cell surface expression of IgE and IgG1. It also regulates the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes and monocytes. . FUNCTION: Participates in at least several B-cell activation processes as well as of other cell types. It is a costimulator of DNA-synthesis. It induces the expression of class II MHC molecules on resting B-cells. It enhances both secretion and cell surface expression of IgE and IgG1. It also regulates the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes and monocytes. . FUNCTION: Participates in at least several B-cell activation processes as well as of other cell types. It is a costimulator of DNA-synthesis. It induces the expression of class II MHC molecules on resting B-cells. It enhances both secretion and cell surface expression of IgE and IgG1. It also regulates the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes and monocytes. . FUNCTION: Participates in at least several B-cell activation processes as well as of other cell types. It is a costimulator of DNA-synthesis. It induces the expression of class II MHC molecules on resting B-cells. It enhances both secretion and cell surface expression of IgE and IgG1. It also regulates the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes and monocytes. . |
Accessions | D4HNR6 ENST00000231449.7 [P05112-1] U3LVN1 ENST00000350025.2 [P05112-2] P05112 ENST00000622422.1 Q6NWP0 B0JFA2 Q5FC01 Q9UPB9 |